Correction to: J Neuroinflammation 17, 99 (2020)
https://doi.org/10.1186/s12974-020-01786-5
Following publication of the original article [1], the authors noticed some mistakes in the published article as follows:
-
Methods, Drug administration:
“Briefly, CYP (25 mg/kg; Sigma, St Louis, MO) was intraperitoneally...” should be corrected as following “Briefly, CYP (50 mg/kg; Sigma, St Louis, MO) was intraperitoneally...”. The dose of CYP we used in this research should be 50 mg/kg (same as described in Abstract) but not 25 mg/kg.
-
2.
The histogram in Fig. 11c is mistakenly used. It is the same as the histogram in Fig. 8c. The Y axis title of Fig. 11d should be corrected to “NR2B/actin (% of Veh)”. Presented here is the corrected Fig. 11.
Fig. 11.
Up- and downregulation of NR2B in the SDH and hippocampus, respectively, were normalized by L-TAMS. Western blot analysis showed that NR2B was upregulated in the SDH (a) but downregulated in the hippocampus (b) of cystitis model rats at the three time points (days 8, 12, and 20 after the first CYP injection). The abnormal expression of NR2B in the SDH (c) or hippocampus (d) was neutralized by oral application of L-TAMS on day 20. *P < 0.05, **P < 0.01, and ***P < 0.001 vs. Veh group, #P < 0.05 and ##P < 0.01 vs. CYP group. Data were analyzed by one-way ANOVA followed by Tukey’s post hoc test
The original article has been updated.
Footnotes
Jia-Liang Chen, Xin Zhou and Bo-Long Liu contributed equally to this work.
Contributor Information
Xian-Guo Liu, Email: liuxg@mail.sysu.edu.cn.
Xiang-Fu Zhou, Email: zhouxfu@mail.sysu.edu.cn.
Reference
- 1.Fortin SP, Johnston SS, Schuemie MJ. Applied comparison of large-scale propensity score matching and cardinality matching for causal inference in observational research. BMC Med Res Methodol. 2021;21:109. doi: 10.1186/s12874-021-01282-1. [DOI] [PMC free article] [PubMed] [Google Scholar]